TCL Archive “Don’t Judge Me On a Snapshot In Time,” Broder Says In Responding To Criticisms By Cancer Centers July 7, 1989
TCL Archive NCI Director Broder’s Year In Review: Avoid Politics, Stay Focused On Science October 28, 1994
TCL Archive Central Oncology Group Phase Out Approved; Board Impressed By Unanimous CCIRC Vote April 2, 1976
TCL Archive FDA Plans to Discuss the Negative Trial of AstraZeneca’s Drug Iressa With the Oncologic Drugs Advisory Committee in March. January 21, 2005
TCL Archive FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview. November 7, 2003
